Cancer drug and antidepressants provide clues for treating brain-eating amoeba infections
Researchers have now identified three new molecular drug targets in Naegleria fowleri and a number of drugs that are able to inhibit the amoeba’s growth in a laboratory dish. Several of these drugs are already approved by the US Food and Drug Administration for other uses, such as antifungal agents, the breast cancer drug tamoxifen […]
Continue Reading →Posted in: AICHC News
Leave a Comment (0) →